How to Ensure Ingredient Compliance for Cosmetics in China: 2026 Guide for Foreign Brands
Summary: Ingredient compliance is the most common reason for NMPA registration rejection — approximately 28% of foreign brand registration applications are rejected or substantially delayed due to non-compliant ingredient disclosures. China’s cosmetics ingredient framework — built on the Catalogue of Used Cosmetic Ingredients (已使用化妆品原料目录, ~8,800 listed ingredients), the List of Prohibited and Restricted Cosmetic Ingredients (化妆品禁用和限用原料目录, 1,496 prohibited substances), and the Technical Specifications for Cosmetics Safety (化妆品安全技术规范, 2025 Edition) — differs materially from EU, US, and Japanese frameworks. This guide provides a systematic approach to ingredient compliance screening, formula adjustment, and documentation preparation for the Chinese market.
Why This Matters
Ingredient compliance is the foundational gate for any cosmetic product entering China. Unlike the EU Cos Regulation or US FDA framework, which rely primarily on manufacturer responsibility and post-market surveillance, China’s NMPA operates a pre-market ingredient approval system. Every ingredient in a cosmetic formula must be affirmatively listed in one of the NMPA’s approved catalogues, or it must undergo a separate New Cosmetic Ingredient (NCI) registration process — a costly and time-consuming undertaking.
The consequences of non-compliance are severe. In 2025, the NMPA issued 127 administrative penalty notices to foreign brands for ingredient violations. Common penalties included product seizure and destruction at port, fines of ¥50,000–500,000 per violation, blacklisting of the importer/CRP, and — in 12 cases — cancellation of the CRP’s registration qualification. Notably, the NMPA has increasingly conducted random ingredient testing at bonded warehouses, with 8.4% of imported cosmetic batches tested in 2025 failing one or more ingredient compliance checks, up from 5.2% in 2024.
For foreign brands, the ingredient compliance process is not merely a regulatory exercise — it directly impacts formulation strategy, product cost, and time to market. A typical ingredient compliance audit takes 2–4 weeks for a 20-ingredient product, costs ¥5,000–15,000 per formula when done by a specialist consultancy, and may require reformulation of 10–30% of product variants depending on the brand’s global ingredient palette.
Ingredient Regulatory Framework Overview
1. The Catalogue of Used Cosmetic Ingredients (CUCI, 已使用化妆品原料目录)
The CUCI (currently Version 2025, ID number is 2025年第X号, published February 2025) contains approximately 8,800 cosmetic ingredients that have been previously registered or recognised in Chinese cosmetic products. Ingredients on this list can be used in cosmetic products without additional ingredient-level registration, provided they comply with concentration limits, purity specifications, and usage restrictions specified in the Technical Specifications.
Key points about the CUCI:
- The list uses INCI names, Chinese common names, and CAS numbers — all three identifiers must match the ingredient being used
- The CUCI includes concentration limits for approximately 1,200 ingredients — if your ingredient concentration exceeds the listed limit, it is effectively a new ingredient for regulatory purposes
- The CUCI is updated every 1–2 years. The 2025 edition added 216 new ingredients and removed 14 that were found to have safety concerns
- Botanical extracts are listed generically (e.g., “Camellia sinensis leaf extract”) — the specific extraction solvent, parts used, and processing method must be disclosed and must fall within the scope of the listed entry
2. The Prohibited and Restricted Ingredients Lists
The NMPA maintains two binding lists that apply to all cosmetics sold in China:
| List | Number of Substances | Legal Basis | Applies To |
|---|---|---|---|
| Prohibited Ingredients List (禁用组分目录) | 1,496 substances | CSAR Art. 14 + Safety Specs 2025 Part 1 | All cosmetics — zero tolerance |
| Restricted Ingredients List (限用组分目录) | 487 substances | CSAR Art. 15 + Safety Specs 2025 Part 2 | Concentration limits, product-type limits, labeling requirements |
The Prohibited List includes substances banned globally (e.g., asbestos, certain phthalates, hydroquinone in leave-on products) and substances specific to Chinese regulation (e.g., certain traditional Chinese medicine ingredients that are permitted in topical TCM preparations but not in cosmetics). The Restricted List specifies maximum concentrations, permitted product categories, and mandatory labeling warnings.
Critical differences from EU/US regulations (2026):
- Hydroquinone: Prohibited in all cosmetics in China (allowed up to 2% for professional use in the US as a skin-bleaching agent under FDA regulation)
- Kojic acid: Restricted to ≤2% in leave-on products (Japan and Korea allow up to 3%)
- Retinol (Vitamin A): Restricted to ≤0.3% in leave-on face products (EU currently has no binding limit, though a proposed restriction to 0.3% is under consultation)
- Alpha arbutin: Restricted to ≤2% in leave-on products (EU and US: no specific limit, treated as a cosmetic active)
- BHT (butylated hydroxytoluene): No specific concentration limit in China (EU restricted to 0.8% for leave-on products; US: generally recognised as safe up to 0.01%)
- Benzophenone-3 (oxybenzone): Maximum 6% in sunscreens (US FDA allows up to 6%); classified as a special cosmetic ingredient (requires sunscreen efficacy testing; UV filter ingredient with specific NMPA approval)
- Methylisothiazolinone (MIT): Prohibited in leave-on products; max 0.0015% in rinse-off products (EU: 0.0015% for rinse-off; US: no specific ban at federal level)
- Parabens: Propylparaben and butylparaben restricted to 0.14% individually, 0.8% total (EU: same; US: no concentration limits but under FDA review)
- Triclosan: Prohibited in all cosmetics except toothpaste up to 0.3% (EU: 0.3% in toothpaste, soap, body wash; US FDA banned from OTC hand soaps in 2016 but allowed in toothpaste)
3. The Technical Specifications for Cosmetics Safety (2025 Edition)
The 2025 edition of the Technical Specifications (化妆品安全技术规范, Huàzhuāngpǐn Ānquán Jìshù Guīfàn) is a comprehensive 1,200-page document covering:
- Physicochemical specifications (pH, viscosity, stability criteria)
- Microbiological limits (total aerobic count ≤100 CFU/g for facial cosmetics; ≤500 CFU/g for body care; no Pseudomonas aeruginosa, Staphylococcus aureus, or Escherichia coli in 1 g)
- Heavy metal limits: Lead ≤10 ppm, Arsenic ≤2 ppm, Mercury ≤1 ppm, Cadmium ≤5 ppm, Antimony ≤2 ppm (new in 2025 edition)
- Specific testing methods for 28 mandatory toxicology studies
- Packaging material migration limits
- Stability testing protocols (accelerated and long-term)
Step-by-Step Ingredient Compliance Process
Step 1: Full Formula Ingredient Audit
Before beginning any NMPA registration or CBEC listing, conduct a complete audit of every ingredient in your formula against the CUCI. The audit should verify:
- Each ingredient is listed in the current (2025) CUCI with matching INCI name, Chinese name, and CAS number
- Concentration of each ingredient is within the permitted range (where limits exist)
- No ingredient from the Prohibited List is present at any concentration
- Product-type restrictions are respected (e.g., an ingredient permitted in rinse-off products may be prohibited in leave-on products)
- Purity specifications are achievable (especially for botanical extracts, where the extraction ratio, solvent, and standardisation markers must be documented)
Tools and resources for the audit:
- NMPA official CUCI database (Excel format, Chinese language, updated February 2025) — available for download from the NMPA ChemiReg portal (https://chemireg.nmpa.gov.cn)
- Cosmetic Ingredient Check API — third-party services like CosIng China, REACH24H, and Intertek offer subscription-based automated ingredient checks (¥15,000–40,000 per year for up to 500 formula checks)
- Manual review by a qualified Chinese cosmetic regulatory consultant (¥5,000–15,000 per formula, 2–4 week turnaround)
Step 2: Identify and Address Gaps
If an ingredient is not in the CUCI, you have three options:
| Option | Description | Timeline | Cost | Best For |
|---|---|---|---|---|
| Reformulate | Replace the non-listed ingredient with a CUCI-approved alternative that provides similar functional or sensory properties | 4–12 weeks (including stability testing) | ¥20,000–80,000 per formula | Brands with <10 SKUs affected; non-core ingredients only |
| Register as NCI | Submit a full NCI registration dossier to the NMPA for the non-listed ingredient | 12–24 months | ¥500,000–2,000,000 per ingredient | Hero hero ingredient critical to product positioning; patented proprietary ingredients |
| Use CBEC route | Sell the product through cross-border e-commerce, which does not require CUCI compliance | 4–8 weeks | ¥50,000–150,000 per SKU | Small-volume products; seasonal or limited editions |
Step 3: Ingredient Concentration Verification
For ingredients on the Restricted List, the NMPA requires the exact concentration to be disclosed in the registration dossier. Ranges are not accepted for restricted ingredients — you must state the exact percentage w/w in the final product. The NMPA cross-references this disclosed concentration against the batch QC testing data, and discrepancies exceeding ±10% of the declared value result in a deficiency letter.
Practical tip: Declare your concentration at the lower end of your manufacturing tolerance range. If your target is 2.0% with a ±0.2% manufacturing tolerance, declare 1.85% in the dossier. This provides a safety buffer against batch-to-batch variation while staying within the permitted limit.
Step 4: Safety Assessment Documentation
Every cosmetic product requires a Cosmetic Safety Assessment Report (化妆品安全评估报告, Huàzhuāngpǐn Ānquán Pínggū Bàogào) prepared by a qualified Chinese safety assessor. The report must cover:
- Toxicological profile of each ingredient (referencing existing safety data, QSAR predictions, or specific studies)
- Aggregate exposure assessment (combining exposure from multiple products that share the same ingredient)
- Margin of Safety (MOS) calculation for each systemically available ingredient — MOS must be ≥100 for general cosmetics
- Stability and compatibility data
- Packaging material migration safety assessment
- Adverse reaction historical data review
The safety assessor must hold a Bachelor’s degree or higher in a relevant discipline (pharmacy, chemistry, toxicology, or food science) with at least 3 years of cosmetic safety evaluation experience. The NMPA maintains a register of qualified safety assessors, which as of early 2026 lists 1,847 individuals.
Step 5: Label and Claims Compliance
Once the ingredient compliance is confirmed, the product label must conform to GB 5296.3-2024 (消费品使用说明 化妆品通用标签, Xiāofèipǐn Shǐyòng Shuōmíng Huàzhuāngpǐn Tōngyòng Biāoqiān). Key requirements:
- All ingredients must be listed in descending order of concentration (ingredients <1% can be listed in any order after the 1% threshold)
- Ingredient names must use the Chinese INCI names from the CUCI — translation from English INCI is not permitted
- Allergen labelling: 26 fragrance allergens must be declared if present above 0.001% in leave-on products or 0.01% in rinse-off products (aligned with EU CosIng but with different threshold for 5 allergens)
- Nanomaterial labelling: Products containing nanomaterials must declare “Contains nanomaterials” (含纳米原料, Hán Nàmǐ Yuánliào) on the label
- Shelf life labelling: Must show both “production date” + “shelf life” (e.g., 生产日期: 2026-06-01, 保质期: 3年) OR “expiry date” (限期使用日期: 2029-06-01)
- Batch number (批号, Pīhào) must be printed or embossed on each retail unit
Common Pitfalls and How to Avoid Them
⚠ Pitfall 1: Assuming CUCI “Equivalence” Between Similar Ingredients
The CUCI lists specific entries. “Tocopherol” and “Tocopheryl acetate” are separate entries. “Sodium hyaluronate” and “Hyaluronic acid” (HA) are separate entries. “Centella asiatica extract” and “Centella asiatica leaf extract” (different plant parts) may be treated as distinct depending on which part is listed. Many foreign brands have had their dossiers returned because they used a CUCI-adjacent ingredient name that did not exactly match the listed entry.
The fix: Do not assume functional or chemical equivalence. If your ingredient source or form differs from the listed CUCI entry (different plant part, different ester form, different salt form), verify with a regulatory consultant before submitting. Reformulation using the exact listed ingredient form is often more cost-effective than attempting a “similar ingredient” argument with the NMPA.
⚠ Pitfall 2: Overlooking Concentration-Dependent Classification Changes
Certain ingredients change regulatory category based on concentration. For example, salicylic acid at ≤0.5% is a permitted preservative in rinse-off products; at 0.5–2.0% it is a restricted cosmetic ingredient (keratolytic) requiring specific labelling (“Contains salicylic acid, not intended for children under 3”); above 2.0% it becomes a drug ingredient requiring NMPA drug approval. Similarly, benzoyl peroxide at ≤2.5% is a regulated cosmetic ingredient for acne-prone skin; above 2.5% it is classified as a pharmaceutical active.
The fix: Map every ingredient against both the CUCI concentration limits and the pharmaceutical ingredient threshold in China’s Drug Administration Law. If your concentration falls in a grey zone (between cosmetic and drug classification), engage a regulatory consultant for a binding classification ruling before proceeding with registration.
⚠ Pitfall 3: Ignoring the Antimony Limit (New for 2025)
The 2025 edition of the Technical Specifications introduced a new heavy metal limit for antimony (Sb) — ≤2 ppm in all cosmetics — that has caught many foreign colour cosmetics brands off guard. Antimony is a common impurity in talc, mica, and certain iron oxide pigments used in eye shadows, blushes, and foundations. Products that passed heavy metal testing under the previous lead/arsenic/mercury/cadmium framework may now exceed the antimony limit.
The fix: Commission an ICP-MS (Inductively Coupled Plasma Mass Spectrometry) analysis of your colour cosmetic formulations for antimony content before beginning NMPA registration. If levels exceed 2 ppm, source alternative talc or pigment suppliers with lower antimony levels. The cost of ICP-MS testing is approximately ¥1,500–3,000 per sample, and reformulation costs vary by the extent of pigment replacement needed.
⚠ Pitfall 4: Using Flavours and Fragrance Allergens Without Documentation
Fragrance formulations are typically treated as trade secrets in Western markets. Chinese regulations require full disclosure of all fragrance ingredients — including each individual aroma chemical — in the NMPA registration dossier. The fragrance supplier must provide a complete formulation breakdown to the brand, who submits it to the NMPA (under confidentiality protection). Failure to disclose leads to dossier rejection.
The fix: Ensure your fragrance supplier (Givaudan, Firmenich, IFF, Symrise, etc.) provides a China-compliant Full Ingredient Disclosure (FID) document for each fragrance compound used in your products. Most major fragrance houses have established China compliance teams and can provide the FID within 2–4 weeks of request. Do not begin NMPA registration without this documentation.
